6-氨基-1-茚酮 | 69975-65-1

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 中文名称: 6-氨基-1-茚酮
• 中文别名: 6-氨基-2,3-二氢-1H-茚-1-酮；6-氨基茚酮
• 英文名称: 6-aminoindan-1-one
• 英文别名: 6-amino-1-indanone；6-amino-2,3-dihydro-1H-inden-1-one；6-aminoindanone；6-amino-2,3-dihydroinden-1-one
• CAS: 69975-65-1
• 化学式: C₉H₉NO
• mdl: MFCD00100747
• 分子量: 147.177
• InChiKey: UOJCPAAEKXNPQT-UHFFFAOYSA-N

物化性质

• 熔点：
  167-171 °C(Solv: methanol (67-56-1))
• 沸点：
  330.3±31.0 °C(Predicted)
• 密度：
  1.254±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2922399090
• WGK Germany：
  3
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H317,H319
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 6-Amino-1-indanone
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 6-Amino-1-indanone
CAS number: 69975-65-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H9NO
Molecular weight: 147.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

6-氨基-1-茚酮是一种合成化合物，属于茚满酮类。它通过多步过程合成，包括胺的脱水和还原胺化，是一种环氧乙烷。在有机化学中，这种化合物用作合成其他多种化合物（如血清素）的中间体。尤其值得注意的是，在进行还原胺化反应时，6-氨基-1-茚酮表现出对钯催化剂的亲和力，并可用于序列优化实验。

反应信息

• 作为反应物：
  描述：

  6-氨基-1-茚酮 在 盐酸 、 sodium nitrite 、 copper(I) bromide 作用下， 以 水 为溶剂， 反应 2.0h， 以71%的产率得到6-溴茚酮
  参考文献：
  名称：

  无金属条件下β-酮基酯的可回收高价碘介导的脱氢α，β'-双官能化

  摘要：

  我们开发了一种在无金属条件下可循环利用的高价碘介导的β-酮酸酯和β-二酮的直接脱氢α，β'-双官能化方法，为合成苯并稠合的2,3-二氢呋喃提供了直接的方法。这种有效，温和的方法具有广泛的底物范围和良好的官能团耐受性，可用于天然酚醛糖苷的受保护糖苷配基的多步合成。提出了一种涉及将迈克尔加成至烯酮中间体并随后进行氧化环化的机理。

  DOI：

  10.1002/chem.201502450
• 作为产物：
  描述：

  1-茚酮 在 硫酸 、 铁粉 、 氯化铵 、 potassium nitrate 作用下， 以 乙醇 、 水 为溶剂， 反应 1.5h， 生成 6-氨基-1-茚酮
  参考文献：
  名称：

  无金属条件下β-酮基酯的可回收高价碘介导的脱氢α，β'-双官能化

  摘要：

  我们开发了一种在无金属条件下可循环利用的高价碘介导的β-酮酸酯和β-二酮的直接脱氢α，β'-双官能化方法，为合成苯并稠合的2,3-二氢呋喃提供了直接的方法。这种有效，温和的方法具有广泛的底物范围和良好的官能团耐受性，可用于天然酚醛糖苷的受保护糖苷配基的多步合成。提出了一种涉及将迈克尔加成至烯酮中间体并随后进行氧化环化的机理。

  DOI：

  10.1002/chem.201502450

文献信息

• Sulfonamides having antiangiogenic and anticancer activity
  申请人：——

  公开号：US20040157836A1

  公开（公告）日：2004-08-12

  Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.

  描述了具有蛋氨酸氨基肽酶-2抑制剂（MetAP2）的化合物。还描述了包括这些化合物的药物组合物、使用这些化合物的治疗方法、抑制血管生成的方法以及治疗癌症的方法。
• Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
  申请人：Lynch K. John

  公开号：US20050209274A1

  公开（公告）日：2005-09-22

  The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

  本发明涉及式(I)的化合物，通过对抗黑素浓集激素（MCH）的作用，通过对抗黑素浓集激素受体，有助于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质稳态、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫、神经退行性疾病和精神障碍。
• High Performance and Active Sites of a Ceria-Supported Palladium Catalyst for Solvent-Free Chemoselective Hydrogenation of Nitroarenes
  作者：Xiuxiu Shi、Xueguang Wang、Xingfu Shang、Xiujing Zou、Weizhong Ding、Xionggang Lu

  DOI：10.1002/cctc.201700631

  日期：2017.10.10

  Cerium oxide‐supported palladium catalysts (Pd/CeO2) prepared by a simple impregnation method exhibit exciting catalytic activity and high chemoselectivity for the solvent‐free hydrogenation of a variety of substituted nitroarenes including the reducible functional groups to the corresponding aromatic amines under mild reaction conditions. Taking nitrobenzene as an example, the Pd/CeO2 catalyst can

  通过简单的浸渍方法制备的氧化铈负载的钯催化剂（Pd / CeO 2）表现出令人兴奋的催化活性和高化学选择性，可在温和反应下对多种取代的硝基芳烃进行无溶剂加氢反应，包括将可还原的官能团还原为相应的芳族胺条件。以硝基苯为例，在40°C和100°C下，Pd / CeO 2催化剂的苯胺收率> 99％，周转频率分别高达11 411 h -1和69 824 h -1。Pd 2+离子物种以孤立的单原子形式存在，在Pd表面具有-Pd 2+ -O 2- -Ce 4+ -键x Ce 1− x O 2− σ固溶体，被发现是在不存在溶剂的情况下硝基芳烃选择性加氢的活性位点。优异的催化性能可归因于Pd 2+离子与CeO 2独特的表面位点之间的协同作用。提出了在Pd / CeO 2上用H 2氢化硝基芳烃的可能机理。Pd / CeO 2催化剂可以很容易地回收，并且可以重复使用至少七个循环反应而不会损失催化性能。
• [EN] SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE<br/>[FR] INHIBITEURS DE HAT SPIROCYCLIQUES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：ABBVIE INC

  公开号：WO2016044770A1

  公开（公告）日：2016-03-24

  Compounds having a structure of Formula (IX) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.

  具有式（IX）的结构或其立体异构体、互变异构体或药学上可接受的盐的化合物，其中R1、R2a、R2b、R3a、R3b、R4a、R4b、Q1----Q2、R6、R7、A、B、W、x和y如本文所定义，并提供。还提供了包括这些化合物的药物组合物和通过给予这些化合物治疗各种HAT相关疾病或疾病，包括癌症的方法。
• The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression
  作者：Xiaokang Li、Jinwen Li、Yunyuan Huang、Qi Gong、Yan Fu、Yixiang Xu、Junyang Huang、Haolan You、Dong Zhang、Dan Zhang、Fei Mao、Jin Zhu、Huan Wang、Haiyan Zhang、Jian Li

  DOI：10.1016/j.ejmech.2021.114045

  日期：2022.2

  pharmacophores of the antidepressant vilazodone (5-HT1A receptor partial agonist and serotonin transporter inhibitor) and the anti-AD drug donepezil (acetylcholinesterase inhibitor) together to develop a series of multi-target-directed ligands for potential therapy of the comorbidity of AD and depression. Accordingly, 55 vilazodone-donepezil chimeric derivatives were designed and synthesized, and their triple-target

  抑郁症是阿尔茨海默病 (AD) 最常见的共病精神症状之一，迄今为止还没有专门为此目的批准的有效药物。在此，我们提出了一种新的治疗策略，将抗抑郁药维拉佐酮（5-HT 1A受体部分激动剂和5-羟色胺转运蛋白抑制剂）和抗AD药物多奈哌齐（乙酰胆碱酯酶抑制剂）的关键药效​​团结合在一起，开发了一系列多靶点。用于潜在治疗 AD 和抑郁症共病的定向配体。因此，设计并合成了 55 种维拉佐酮-多奈哌齐嵌合衍生物，以及它们对乙酰胆碱酯酶 5-HT 1A的三靶点活性。受体和血清素转运蛋白进行了系统评估。其中，化合物5在体外表现出很强的三靶点生物活性、低hERG钾通道抑制和可接受的脑分布。重要的是，口服 5 mg/kg 的化合物5二盐酸盐可显着减轻小鼠模型的抑郁症状并改善认知功能障碍。简而言之，这些结果突出了维拉佐酮-多奈哌齐嵌合体作为治疗 AD 和抑郁症合并症的前瞻性治疗方法。